EUVIMEDEUVIMED entdecken
Crossref

Clinical significance of carbapenem synergism in combination with reserve antibiotics: a retrospective study in patients with carbapenem-resistant infections

Akhmedova Salikhat Makhachevna, Musayeva Khadijat Niyazbekovna, Magomedova Farida Rashidovna, Alieva Dzhamilya Zainulabitovna, Magomedova Dzhamilya Rizvanovna Magomedova Dzhamilya Rizvanovna, Kurbanismailova Aisha Kurbanismailovna, Magomedova Taibat Magomedrasulovna, Khalilov Khalil Magomedovich, Abakarova Saniyat Makamagomedovna, Saidova Madina Shakhbanovna

International Journal of Drug Delivery Technology · 27.06.2026 · 16 (58s)

DOI: 10.25258/ijddt.16.58s.34 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 27.06.2026. Verfasst von Akhmedova Salikhat Makhachevna und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the clinical significance of carbapenems synergism in combination with reserve antibiotics in patients with carbapenem-resistant infections based on a retrospective analysis of treatment results.

Methods

A single-center retrospective cohort study was conducted that included 186 adult patients with microbiologically confirmed carbapenem-resistant infections. All patients received combined antibacterial therapy, including carbapenem and a reserve antibiotic. The synergism of antibiotic combinations was determined by the checkerboard assay with the calculation of the fractional inhibitory concentration index (FICI). The patients were divided into the synergism group (n = 112) and the non-synergism group (n = 74). The primary outcome was a 30-day mortality rate. Secondary outcomes included clinical recovery, microbiological eradication of the pathogen, duration of hospitalization, and frequency of adverse drug reactions.

Results

A synergistic effect was found in 60.2% of patients. The rate of clinical recovery in the synergy group was 79.5% versus 56.8% in the no-synergy group (p = 0.001). Microbiological eradication was achieved in 72.3% and 47.3% of patients, respectively (p = 0.002). Thirty-day mortality was significantly lower in the synergism group (23.2% vs. 44.6%; p = 0.002). In multifactorial logistic analysis, lack of synergy was an independent predictor of death (OR 2.41; 95% CI 1.18–4.92; p = 0.016). In addition, the use of synergistic combinations was accompanied by a reduction in the length of stay in the intensive care unit and the total duration of hospitalization. There were no significant differences in the frequency of adverse drug reactions between the groups.

Conclusion

The laboratory-proven synergy of carbapenems with reserve antibiotics is associated with improved clinical outcomes in patients with carbapenem-resistant infections, including reduced mortality and increased clinical recovery rates. The results obtained confirm the prospects of using synergism testing for a personalized choice of antibacterial therapy and justify the need for further prospective studies.

Zitieren

APA

Makhachevna, A. S., Niyazbekovna, M. K., Rashidovna, M. F., Zainulabitovna, A. D., Rizvanovna, M. D. R. M. D., Kurbanismailovna, K. A., Magomedrasulovna, M. T., Magomedovich, K. K., Makamagomedovna, A. S., & Shakhbanovna, S. M. (2026). Clinical significance of carbapenem synergism in combination with reserve antibiotics: a retrospective study in patients with carbapenem-resistant infections. International Journal of Drug Delivery Technology, 16(58s). https://doi.org/10.25258/ijddt.16.58s.34

Vancouver

Makhachevna AS, Niyazbekovna MK, Rashidovna MF, Zainulabitovna AD, Rizvanovna MDRMD, Kurbanismailovna KA, et al. Clinical significance of carbapenem synergism in combination with reserve antibiotics: a retrospective study in patients with carbapenem-resistant infections. International Journal of Drug Delivery Technology. 2026;16(58s). doi:10.25258/ijddt.16.58s.34

BibTeX
@article{Makhachevna2026,
  author = {Makhachevna, Akhmedova Salikhat and Niyazbekovna, Musayeva Khadijat and Rashidovna, Magomedova Farida and Zainulabitovna, Alieva Dzhamilya and Rizvanovna, Magomedova Dzhamilya Rizvanovna Magomedova Dzhamilya and Kurbanismailovna, Kurbanismailova Aisha and Magomedrasulovna, Magomedova Taibat and Magomedovich, Khalilov Khalil and Makamagomedovna, Abakarova Saniyat and Shakhbanovna, Saidova Madina},
  title = {Clinical significance of carbapenem synergism in combination with reserve antibiotics: a retrospective study in patients with carbapenem-resistant infections},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {58s},
  doi = {10.25258/ijddt.16.58s.34}
}
Kostenlos starten →